Discover
PTHS
Pelthos Therapeutics Inc.
26.86
1 x 26.67
1 x 28.47
bid
ask
-
0.40
1.47%
04:00 PM
| Ytd | -13.35% | |
| 1y | 35.38% |
26.14
day range
27.85
16.50
52 week range
37.50
| Open | 27.15 | Prev Close | 27.26 | Low | 26.14 | High | 27.85 | Mkt Cap | 17.42M |
| Vol | 66.24K | Avg Vol | 26.61K | EPS | -16.60 | P/E | -1.62 | Forward P/E | N/A |
| Beta | 3.10 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 27.00 | 200-d Avg | 26.13 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 10.91M | ||
| Revenues (USD) | 10.91M | ||
| Cost of Revenue | 1.67M | ||
| Gross Profit | 9.23M | ||
| Operating Expenses | 22.32M | ||
| Research and Development Expense | 186.00K | ||
| Selling, General and Administrative Expense | 21.10M | ||
| Operating Income | -13.09M | ||
| Interest Expense | 2.35M | ||
| Net Income | -10.24M | ||
| Net Income Common Stock | -10.24M | ||
| Net Income Common Stock (USD) | -10.24M | ||
| Consolidated Income | -10.24M | ||
| Earnings per Basic Share | -3.09 | ||
| Earnings per Basic Share (USD) | -3.09 | ||
| Earnings per Diluted Share | -3.09 | ||
| Earning Before Interest & Taxes (EBIT) | -7.88M | ||
| Earning Before Interest & Taxes (USD) | -7.88M | ||
| Weighted Average Shares | 3.31M | ||
| Weighted Average Shares Diluted | 3.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 32.23M | ||
| Cash and Equivalents (USD) | 32.23M | ||
| Trade and Non-Trade Receivables | 11.70M | ||
| Current Assets | 69.80M | ||
| Property, Plant & Equipment Net | 12.46M | ||
| Total Assets | 145.38M | ||
| Debt Current | 640.00K | ||
| Total Debt | 52.93M | ||
| Current Liabilities | 25.00M | ||
| Debt Non-Current | 52.29M | ||
| Total Liabilities | 110.28M | ||
| Accumulated Retained Earnings (Deficit) | -75.03M | ||
| Accumulated Other Comprehensive Income | 3.19M | ||
| Shareholders Equity | 35.10M | ||
| Shareholders Equity (USD) | 35.10M | ||
| Assets Non-Current | 75.58M | ||
| Total Debt (USD) | 52.93M | ||
| Deferred Revenue | 2.01M | ||
| Goodwill and Intangible Assets | 63.12M | ||
| Inventory | 23.42M | ||
| Liabilities Non-Current | 85.27M | ||
| Trade and Non-Trade Payables | 6.15M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.57M | ||
| Net Cash Flow from Financing | 27.52M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 14.20M | ||
| Capital Expenditure | -194.00K | ||
| Issuance (Repayment) of Debt Securities | 27.52M | ||
| Net Cash Flow from Investing | -194.00K | ||
| Net Cash Flow from Operations | -13.13M | ||
| Share Based Compensation | 1.91M | ||